BREAST CARCINOMA
Breast cancer is the most common (30%) of all cancers
and is the second (next to lung cancer) common cause
of cancer deaths in women. One out of 8 obstetric-
gynecologic patients is likely to develop breast
Tumor of breast
carcinoma at sometime during her adult life in USA
and Western countries.
Obstetricians-gynecologists examine millions of
patients on a regular basis. As such, they are expected
to evaluate breast problems with a breast oriented
history, physical examination, cytology and imaging
studies for to formulate the management
Screening for Breast Cancer:
Breast
carcinomas are generally without any symptoms to
start with. Screening can detect breast cancer at an
earlier stage. Ideally screening should
be performed for all women from 40 years of age.
Earlier detection improves the survival rate. Five-
year survival is about 85 percent when axillary lymph
nodes are not involved.
Screening and diagnostic methods include:
1. Breast self examination.
2. Clinical breast examination (CBE) by a physician
- Inspection - Palpation.
3. Breast imaging
Screening mammography.
Diagnostic mammography.
Ultrasonography.
Magnetic resonance imaging (MRI).
Digital mammography, positron emission
tomography.
4. Breast biopsy
Fine needle aspiration biopsy (FNAB).
Stereotactic and ultrasound guided core
biopsy.
Open biopsy:
- Excisional biopsy
- Incisional biopsy.
Breast self examination (BSE)
Breast self examination should be made into a
habit, certainly by the age of 20. The examination
should be made on a monthly basis following the
menses as the breasts become less tender and less
engorged.
The procedures (as described above) are demon-
strated to the patient. Circular method of palpation
is easy to do. Inspection should be done standing in
front of a mirror in a well lit-room. The patient should
palpate her breasts with the opposite hand both in
sitting position and lying supine with a pillow beneath
her back. Axillary and supraclavicular areas are to
be palpated. The nipples should be compressed for
any discharge. She is instructed to contact physician
whenever there is any abnormal finding.
Clinical Breast Examinations (CBE)
Inspection
Inspection is performed while the patient is
sitting with arms relaxed by her sides. Both the
breasts are observed for contour, symmetry, nipple
positions, and any skin changes. Patient is asked
to press her hands on her hips so as to contract the
pectoralis major muscles. Skin dimpling and nipple
retraction if any, may be obvious with this method.
Palpation
Entire breast is palpated methodically by quadrant
with the pads of the fingers (most sensitive) both in
upright and in supine positions
Generally, a malignant mass is felt firm, non-
tender, fixed with ill-defined borders. Entire axilla
and the supraclavicular areas are palpated for any
lymph nodes. Nipple is compressed for any discharge.
High risk factors for breast
carcinoma
• Early menarche • Late menopause
• Obesity • Nulliparity
• Late age of first birth (>35 years)
• Never breastfed
• Atypical lobular hyperplasia
• Nipple discharge other than milk
• High dose breast or chest irradiation
• High dietary fat intake • Alcohol consumption
• Estrogen replacement therapy
• Breast carcinoma in first degree relative
(Mother, sister or daughter)
• Carcinoma in the other breast
• Previous cancer of endometrium, ovary, colon
• Inherited mutations of BRCA1 and BRCA 2 genes
Genetic predisposition—is high when there is
mutation of the BRCA 1 (on chromosome 17 q) and/
or BRCA 2 (on chromosome 13 q) genes. BRCA 1 and
BRCA 2 are the tumor suppressor genes. Hereditary
breast cancer is seen in younger women and is often
bilateral. Around 5% of breast cancers are familial.
Breast cancer screening guidelines
(ACOG-2000)
1. Age 20–39
- BSE monthly
- CBE yearly
2. Age 40-49
- BSE monthly
- CBE yearly
- MGY—every 1–2 yrs.
3. Age 50
- BSE monthly
- CBE yearly
- MGY yearly
Breast Imaging
1. Mammography (MGY)
2. Digital mammography (DM)
3. Ultrasonography
4. MRI
5. PET
6. Fine-needle aspiration cytology (FNAC)
7. Core Needle Biopsy (CNB)
8. Triple test includes
9. Open biopsy
Staging of Breast Cancer:
Breast cancer is
staged clinically according to tumor size, regional
lymph node involvement and distant metastasis
American Joint Committee on
Cancer Staging (2003) reclassified the nodal status
by number of involved lymph nodes, use of sentinal
lymph node biopsy. Complete staging includes a
thorough history, physical examination, bilateral
mammography, pretreatment chest radiography,
routine blood values, pathology slides with estrogen
receptor, progesterone receptor and HER 2 status
along with breast MRI.
Staging helps to compare the results of trials
throughout the world. This is also helpful to develop
uniform treatment regimens.
For staging of breast cancer readers should consult
any textbook of surgery.
~ Thank you for reading ......
0 Comments